Patent Oppositions in enzyme processing industry

Explore the competitive field of enzyme processing where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in enzyme processing technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the enzyme processing industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the enzyme processing industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Feb 12, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Rna-Guided Human Genome EngineeringPRESIDENT AND FELLOWS OF HARVARD COLLEGEJan 30, 2026SCHLICH
Rna-Guided Human Genome EngineeringPRESIDENT AND FELLOWS OF HARVARD COLLEGEDec 30, 2025VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence ManipulationPRESIDENT AND FELLOWS OF HARVARD COLLEGEDec 19, 2025GRUND GROUP PATENTANWALTE UND SOLICITOR PARTG MBB
Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic ApplicationsTHE BROAD INSTITUTEDec 12, 2025GRUND IPG PATENTANWALTE UND SOLICITOR PARTG MBB
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionTHE REGENTS OF THE UNIVERSITY OF CALIFORNIANov 26, 2025POHLMAN
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionTHE REGENTS OF THE UNIVERSITY OF CALIFORNIANov 25, 2025HGF
System And Method For Genome EditingINSTITUTE OF ZOOLOGYSep 11, 2025STRAWMAN
A Process For The Production Of A Baked Product Without Addition Of SugarLANTMNNEN UNIBAKE HOLDINGJul 22, 2025NOVOZYMES
Downy Mildew Resistance Providing Genes In SunflowerSCIENZA BIOTECHNOLOGIES 5Jul 16, 2025SOLTIS LIMAGRAIN EUROPE LIDEA FRANCE
Process For Enzymatic Oil DegummingDSM ASSETSJul 8, 2025CABINET BECKER ET ASSOCIES

To stay ahead in the competitive enzyme processing industry, companies are constantly innovating. Here are the top patents facing oppositions in the enzyme processing industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Feb 12, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Sep 20, 2017Crispr-Based Genome Modification And RegulationSIGMA ALDRICH10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10
Dec 5, 2018Crispr-Based Genome Modification And RegulationSIGMA ALDRICH9
Oct 2, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH8
Oct 9, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH8
Nov 27, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH7
Dec 5, 2018Crispr-Based Genome Modification And RegulationSIGMA ALDRICH6
Aug 22, 2018Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use ThereofTOOLGEN INCORPORATED6
Oct 12, 2022Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing ImmunoglobulinsINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE6
Jun 13, 2018Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionUNIQURE BIOPHARMA5